Wire
Anixa Biosciences Says Canadian IP Office Issues Notice of Allowance for Patent Covering Ovarian Cancer Vaccine Technology
Anixa Biosciences (ANIX) said Monday that the Canadian Intellectual Property Office has issued a notice of allowance for a patent covering the company's ovarian cancer vaccine technology.The patent, exclusively licensed from Cleveland Clinic, includes methods of administering an immunogenic composition comprising a nucleic acid encoding the anti-Mullerian hormone receptor 2 polypeptide, the company said.Price: $2.72, Change: $+0.02, Percent Change: +0.74%
$ANIX
